IMPELLER ASSEMBLIES FOR FLUID PROCESSING SYSTEMS
    91.
    发明申请
    IMPELLER ASSEMBLIES FOR FLUID PROCESSING SYSTEMS 审中-公开
    用于流体加工系统的叶轮组件

    公开(公告)号:WO2015148187A1

    公开(公告)日:2015-10-01

    申请号:PCT/US2015/021037

    申请日:2015-03-17

    Abstract: A fluid mixing system includes a flexible bag (12) having an interior surface bounding a compartment. An elongated first tubular connector (80) is disposed within the compartment of the flexible bag, the first tubular connector having a first end and an opposing second end, the first end of the first tubular connector being coupled with the flexible bag. An elongated second tubular connector (84) is disposed within the compartment of the flexible bag, the second tubular connector being more rigid than the first tubular connector and having a first end coupled to the second end of the first tubular connector. A plurality of impellers (85A-C) are disposed on the elongated second tubular connector at spaced apart locations.

    Abstract translation: 流体混合系统包括具有限定隔室的内表面的柔性袋(12)。 细长的第一管状连接器(80)设置在柔性袋的隔室内,第一管状连接器具有第一端和相对的第二端,第一管状连接器的第一端与柔性袋结合。 细长的第二管状连接器(84)设置在柔性袋的隔室内,第二管状连接器比第一管状连接器更刚性并且具有联接到第一管状连接器的第二端的第一端。 多个叶轮(85A-C)在间隔开的位置设置在细长的第二管状连接器上。

    SYSTEMS AND METHODS FOR DIAGNOSING A FLUIDICS SYSTEM AND DETERMINING DATA PROCESSING SETTINGS FOR A FLOW CYTOMETER
    92.
    发明申请
    SYSTEMS AND METHODS FOR DIAGNOSING A FLUIDICS SYSTEM AND DETERMINING DATA PROCESSING SETTINGS FOR A FLOW CYTOMETER 审中-公开
    用于诊断流体系统的系统和方法以及确定流量计的数据处理设置

    公开(公告)号:WO2015134139A1

    公开(公告)日:2015-09-11

    申请号:PCT/US2015/014210

    申请日:2015-02-03

    Abstract: The present set of embodiments relates to systems and methods for diagnosing a fluidics system and determining data processing settings for a flow cytometer. Systems and methods for diagnosing a fluidics system require accurate measurement and interpretation of fluctuations within the fluid delivery system. Systems and methods for determining data processing settings require an accurate measurement of peak times among various channels and being able to adjust time delay settings wherein peak time is the measurement of time elapsed from the beginning of the data collection time window to the highest peak in the window.

    Abstract translation: 本组实施例涉及用于诊断流体系统并确定流式细胞仪的数据处理设置的系统和方法。 用于诊断流体系统的系统和方法需要准确测量和解释流体输送系统内的波动。 用于确定数据处理设置的系统和方法需要精确测量各种通道中的峰值时间,并且能够调整时间延迟设置,其中峰值时间是从数据采集时间窗口开始到数据采集时间窗口的最高峰值的时间的测量 窗口。

    SYSTEMS AND METHODS FOR DETECTING STRUCTURAL VARIANTS
    96.
    发明申请
    SYSTEMS AND METHODS FOR DETECTING STRUCTURAL VARIANTS 审中-公开
    用于检测结构变量的系统和方法

    公开(公告)号:WO2015050919A1

    公开(公告)日:2015-04-09

    申请号:PCT/US2014/058517

    申请日:2014-10-01

    Abstract: Systems and method for identifying long deletions can obtain sequencing information for a plurality of amplicons in and around a potential region from a nucleic acid sample. The sequencing information can include a plurality of reads that can be mapped to a reference sequence. Using information, such as where reads map to a reference sequence and relative abundance of reads for the amplicons, structural variants can be identified and a determination can be made if the nucleic acid sample is homozygous or heterozygous for the structural variant.

    Abstract translation: 用于识别长缺失的系统和方法可以获得核酸样品的潜在区域内和周围的多个扩增子的测序信息。 排序信息可以包括可以映射到参考序列的多个读取。 使用诸如读数映射到扩增子的参考序列和相对丰度的信息的信息,可以鉴定结构变体,并且如果核酸样品对于结构变体是纯合的或杂合的,则可以进行确定。

    PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA
    100.
    发明申请
    PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA 审中-公开
    慢性细胞肺癌的预后测定

    公开(公告)号:WO2014151955A1

    公开(公告)日:2014-09-25

    申请号:PCT/US2014/026724

    申请日:2014-03-13

    CPC classification number: C12Q1/686 C12Q1/6886 C12Q2600/118 C12Q2600/156

    Abstract: Prognosis methods for predicting clinical outcome for a human subject diagnosed with squamous cell lung carcinoma using a panel of molecular markers that includes CDKN2A and CCND1. CDKN2A / p16 deletion or loss of function mutation and CCND1 amplification are related to the subject's increased likelihood of a negative clinical outcome.

    Abstract translation: 使用包括CDKN2A和CCND1的分子标记的一组来预测诊断为鳞状细胞肺癌的人类受试者的临床结果的预后方法。 CDKN2A / p16缺失或缺失功能突变和CCND1扩增与受试者增加阴性临床结局的可能性有关。

Patent Agency Ranking